Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics, another ...
Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscle weakness and intellectual disability. DMD is an inherited (passed down) disorder. The condition is linked ...
Werner is CEO of Alltrna and CEO-partner at Flagship Pioneering. Duchenne muscular dystrophy has seen more progress in the past 15 months (give or take) than in the last couple of decades combined. In ...
Forbes contributors publish independent expert analyses and insights. William A. Haseltine, Ph.D., covers genomics and regenerative medicine Today, the world stands at a crossroads in genetic medicine ...
Biotech firm Sarepta Therapeutics said that a second patient died after receiving its gene therapy to treat Duchenne muscular dystrophy, the latest drug to draw scrutiny after winning fast regulatory ...
Lousin Mehrabi is a negotiation professional, inspirational speaker, trainer and advisor in negotiations, emotional intelligence and leadership. She is also the mother of Alex, 11, who has Duchenne ...
A major trial of a promising gene therapy for Duchenne muscular dystrophy has fallen short, but researchers say the lessons learned could pave the way for better, more effective treatments. A newpaper ...
Treating Duchenne muscular dystrophy before symptoms emerge may improve motor function, clinical trial suggests by Ethan Knox, Binghamton University edited by Lisa Lock, reviewed by Robert Egan ...
Asianet Newsable on MSN
SRPT stock drops 4% as Citi flags potentially stronger rival in Duchenne space
Citi reiterated a ‘Sell’ rating on SRPT, citing the expected rise in competition within the Duchenne muscular dystrophy (DMD) ...
More than 30 rare muscular dystrophy types cause progressive muscle weakness from inherited gene mutations. Combined, they affect about 1 in 5,000 to 8,000 people. Common subtypes vary by age of onset ...
Venture investors have staked SonoThera $125 million in new capital, hoping the startup’s technology will revolutionize the treatment of Duchenne muscular dystrophy and other diseases. SonoThera is ...
A Northwestern Medicine study has uncovered how chronic defects in muscle membrane repair can fuel harmful inflammation. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results